http://www.biospace.comBioSpace RSS GeneratorThu, 23 May 2013 01:31:24 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.renaissancecapital.com/ipohome/news/AutoGenomics-pulls-$60-million-IPO-13658.htmlAutoGenomics, which provides a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its IPO on Friday, according to an underwriter.Tue, 19 Feb 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/01/08/bauschlomb-ceo-idUSL1E9C8D4L20130108Eye care company Bausch & Lomb is focused on future growth at the same time it is "aspiring to return to public markets," Chief Executive Officer Brent Saunders said following a presentation here. He declined to comment on reports that Warburg Pincus, which took the company private in 2007 for about $4.5 billion, including $830 million in debt, is looking for buyers willing to pay more than $10 billion...Thu, 10 Jan 2013 12:00:00 AM GMThttp://www.pehub.com/158213/bausch-lomb-eyes-2012-ipo-report/Bausch & Lomb, the eye care company that was taken private at the height of the past LBO boom, could soon file paperwork to go public, according to a report in the Wall St. Journal. Bausch & Lomb was acquired for about $4.5 billion in 2007 by Warburg Pincus. Bausch & Lomb could go public as early as the end of this year, the Wall Street Journal reported, citing people familiar with the companys thinking...Fri, 06 Jul 2012 12:00:00 AM GMThttp://www.memphisdailynews.com/news/2012/may/23/memphis-based-mri-interventions-goes-public/Memphis Business Journal by Michael Sheffield, Staff writer</p><p>Memphis company MRI Interventions officially launched its initial public offering this week.</p><p>The company makes and markets a minimally invasive neurosurgical system called ClearPoint, which uses MRI scanners to pinpoint designated areas in the brain for surgery. The device enables surgeons to perform surgeries while patients...Wed, 23 May 2012 12:00:00 AM GMThttp://medcitynews.com/2012/05/new-cfo-for-tearscience-as-the-device-firm-weighs-acquisition-ipo-plans/?edition=medical-devicesDry eye treatment company TearScience, which is considering plans for an initial public stock offering, now has a new chief financial officer. The medical device company has promoted Nicole Wicker from vice president of finance to CFO. Wicker joined TearScience in 2008 and guided the Morrisville, North Carolina company through its $44.5 million series C round of fundraising in 2010, which brought on...Thu, 17 May 2012 12:00:00 AM GMThttp://www.genomeweb.com/mdx/update-cancer-genetics-plans-486m-ipoApproximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. If this Form is filed to register additional securities for an offering pursuant...Tue, 15 May 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=260245&full=1<div class"xn-content"><p><span class"xn-location">SAN CLEMENTE, Calif.</span>, <span class"xn-chron">May 14, 2012</span> /PRNewswire/ -- ICU Medical, (NASDAQ:ICUI) today announced that it would "vigorously seek to collect damages" as a result of its patent infringement victory over RyMed. ICU Medical filed a lawsuit in 2007 to stop RyMed Technologies from selling its patent-infringing In-Vision...Mon, 14 May 2012 12:00:00 AM GMThttp://www.lifescientist.com.au/article/423091/ventus_medical_launches_40m_ipo/SYDNEY, AUSTRALIA 30 April 2012 Ventus Medical, Inc., a US based medical device company, has today announced its intention to raise A$40 million through an initial public offer. Ventus Medical is also seeking to list on the Australian Securities Exchange (ASX) under the ticker VNT.</p><p>We are excited to be listing in Australia, the birthplace of sleep medicine and a very important market...Tue, 01 May 2012 12:00:00 AM GMThttp://www.cambridge-news.co.uk/Business/Business-News/Sphere-Medical-at-Harston-to-float-on-AIM-20102011.htmCambridge UK based Sphere Medical, which is poised to revolutionise monitoring within intensive care diagnostics, is raising 15m via a placing and heading for an IPO on Londons AIM market.Sphere plans to raise the cash through institutional and other investors. The AIM float is expected to take place before the end of November. Peel Hunt LLP has been appointed nominated adviser and broker to the...Thu, 20 Oct 2011 12:00:00 AM GMThttp://www.reuters.com/article/2011/10/13/us-bauschlomb-idUSTRE79C71P20111013?feedType=RSS&feedName=innovationNews&rpc=43After four years in private hands, Bausch & Lomb may soon head back to the public market as Chief Executive Brent Saunders is setting sights on an IPO for the U.S. eye-care giant "in the next couple of years." Saunders, a CEO of a year and a half, is also focusing on at least two other targets: growth in emerging markets and boosting the company's pharmaceutical business. "The hidden gem of our business...Fri, 14 Oct 2011 12:00:00 AM GMThttp://www.reuters.com/article/2011/10/07/zeltiq-idUSL3E7L71ZO20111007Zeltiq Aesthetics Inc. unveiled estimated terms for a slightly smaller initial public offering as the company aims to raise funds to commercialize its fat-bulge reduction technology. The IPO of 7 million shares includes 6.7 million shares from the company and 307,000 shares from selling stockholders, according to its filing with the filing with the U.S. Securities and Exchange Commission. The estimated...Fri, 07 Oct 2011 12:00:00 AM GMThttp://www.rttnews.com/ArticleView.aspx?Id=1650473&SM=1Mauna Kea Technologies could raise as much as 47.6 million euros ($67.73 million) from its initial public offering, the proceeds of which it plans to use to speed up sales of the world's smallest microscope that can be used to examine the inside of the human body. France's Mauna Kea said on Tuesday the price range of its IPO on the NYSE Euronext stock exchange was set between 10.65 euros and 13 euros...Thu, 23 Jun 2011 12:00:00 AM GMThttp://www.reuters.com/article/2011/06/20/us-agendia-idUSTRE75J62E20110620AMSTERDAM and IRVINE, California, June 20, 2011 /PRNewswire/ --</p><p>- Not for release, distribution or publication in whole or in part, directly or indirectly, into or in the United States, Australia, Canada, OR Japan</p><p>Agendia (or the "Company"), a commercial-stage molecular cancer diagnostics company, announces the postponement of its Initial Public Offering ("IPO") that was due to...Wed, 22 Jun 2011 12:00:00 AM GMThttp://www.xconomy.com/san-diego/2011/05/19/autogenomics-withdraws-ipo/In a letter to federal regulators yesterday, Carlsbad, CA-based AutoGenomics withdrew its filing for an initial public offering, which the company submitted in July, 2008. The company said at that time that its IPO would be made only by means of a prospectus, with J.P. Morgan Securities Inc. acting as the sole book-running manager of the offering. CEO Fareed Kureshy gave no reason for withdrawing...Fri, 20 May 2011 12:00:00 AM GMThttp://online.wsj.com/article/BT-CO-20110415-713739.htmlWSJ -- Lucid Inc. filed plans to sell up to $28.8 million of common stock in an initial public offering, as the medical-device maker seeks to raise money to repay debt and build its global research and sales.Tue, 19 Apr 2011 12:00:00 AM GMThttp://www.streetinsider.com/IPOs/Brainsway+Ltd.+%28BRIN%29+Files+$30M+IPO/6422376.htmlStreet Insider -- Brainsway Limited (Nasdaq: BRIN) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Ordinary Shares. The proposed maximum offering amount is $30 million. Brainsway filed to list on the Nasdaq Capital Market under the ticker "BRIN."Tue, 12 Apr 2011 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=216614&full=1MISGAV, ISRAEL and VIENNA, VA--(Marketwire - 04/08/11) - Medgenics, Inc. (AMEX:MDGN - News) (AMEX:MDGN.W - News) (AIM: MEDG) (AIM: MEDU), the company that has developed a novel technology for the sustained manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, today announced the pricing of its initial underwritten public offering in the United States of ...Fri, 08 Apr 2011 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=210441&full=1MINNEAPOLIS</span>, <span class"xn-chron">Feb. 10, 2011</span> /PRNewswire/ -- Kips Bay Medical, Inc. (Nasdaq: KIPS) announced today the pricing of the Company's initial public offering of 2,062,500 shares of its common stock at a price of <span class"xn-money">$8.00</span> per share. The shares are expected to begin trading on <span class"xn-chron">February 11, 2011</span> on the NASDAQ Global...Fri, 11 Feb 2011 12:00:00 AM GMThttp://www.forbes.com/feeds/ap/2011/02/10/business-us-fluidigm-ipo-pricing_8301641.htmlSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluidigm Corporation today announced the pricing of its initial public offering of 5,558,333 shares of its common stock at a price to the public of $13.50 per share. The shares of common stock have been approved to trade on The NASDAQ Global Market under the symbol FLDM.</p><p>Deutsche Bank Securities Inc. and Piper Jaffray & Co. are acting as joint...Thu, 10 Feb 2011 12:00:00 AM GMThttp://www.xconomy.com/boston/2011/02/04/bg-medicine-goes-public-at-7-per-share/Xconomy -- Waltham, MA-based BG Medicine (NASDAQ: BGMD) started trading publicly today at $7 per share. After indicating earlier in the week that it had planned to offer 4.75 million shares in its initial public offering, the diagnostics company sold 5 million shares. Lazard Capital Markets acted as sole book-running manager for the deal, and underwriters will have the 30-day option to purchase an...Mon, 07 Feb 2011 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=209453&full=1AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (the Company) announced today the pricing of its initial public offering of 8,750,000 of the Companys ordinary shares at a price to the public of $19.00 per share, all of which were offered by Tornier N.V. The ordinary shares are expected to begin trading February 3, 2011, on the Nasdaq Global Select Market under the symbol "TRNX." BofA Merrill Lynch and...Thu, 03 Feb 2011 12:00:00 AM GMThttp://www.pehub.com/93425/tornier-bv-trims-ipo-size-to-1838million-from-205-million-%E2%80%93-reuters/Pehub -- Warburg Pincus-backed Tornier B.V. expects to raise up to $183.8 million when it goes public on Nasdaq, which is lower than the $205 million initial public offering previously planned, Reuters reported. Tornier is a Netherlands-based medical device company. It expects its IPO of 8.8 million shares will be priced at the range of $19 to $21 each. Thu, 20 Jan 2011 12:00:00 AM GMThttp://www.renaissancecapital.com/ipohome/news/Medical-device-company-Kips-Bay-Medical-announces-IPO-terms-8931.htmlRenaissance Capital -- Kips Bay Medical, which is developing vein support technology to be used in coronary artery bypass grafting (CABG) surgery, announced terms for its IPO on Tuesday. The Minneapolis, MN-based company plans to raise $25 million by offering 2.75 million shares at a price range of $8-$10. Wed, 19 Jan 2011 12:00:00 AM GMThttp://www.globes.co.il/serveen/globes/docview.asp?did=1000613703&fid=1725Globes -- IceCure Medical published a draft prospectus today for an offering on the Tel Aviv Stock Exchange. The company intends to raise some NIS 30 million. This draft is the first published by a biomed company after five offerings by such companies were cancelled in the previous quarter. Thu, 06 Jan 2011 12:00:00 AM GMThttp://www.globes.co.il/serveen/globes/docview.asp?did=1000605841&fid=1725Globes -- The IPO of Check Cap, which has developed a capsule for locating polyps in the colon, has been cancelled, because the company failed to achieve a valuation of $70 million. Sources close to the company told "Globes" that the IPO could probably have taken place at a valuation of $55 million, but the company preferred to forego it and to use its cash, $5 million, to carry out a clinical trial...Tue, 07 Dec 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=199760&full=1PRINCETON, N.J., and PARIS, Oct. 28, 2010-Stentys, a medical technology company that markets a new generation of innovative stents to treat Acute Myocardial Infarction (AMI), announced today that its shares are now listed and traded on the NYSE Euronext Paris (Ticker: STNT).<p></p>As a result of this IPO, Stentys has raised $31.9 million (22.7 million), which will be used to commercialize its innovative...Thu, 28 Oct 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=194058&full=1<div id"releaseBody"><p>ROCKVILLE, MD and SEOUL, KOREA--(Marketwire - September 13, 2010) - Seegene today announced its successful initial public offering on the KOSDAQ (Korea Securities Dealers Automated Quotations). The company sold 636,500 shares for USD 26.16 (WON 30,500) each, raising USD 16.6 million and giving Seegene a market capitalization of USD 167 million. The company plans to invest...Mon, 13 Sep 2010 12:00:00 AM GMThttp://www.reuters.com/article/idUSHKV00250020100910HONG KONG, Sept 10 (Reuters) - MicroPort Scientific Corp. is seeking to raise up to $198 million through a Hong Kong IPO, according to a term sheet released on Friday.Mon, 13 Sep 2010 12:00:00 AM GMThttp://www.xconomy.com/san-diego/2010/09/07/san-diegos-zogenix-files-for-90m-ipo-to-expand-development-of-needle-free-injector-and-pain-drugs/<div class"xn-content"><p><span class"xn-location">SAN DIEGO</span>, <span class"xn-chron">Sept. 7</span> /PRNewswire/ -- Zogenix, Inc. ("Zogenix") announced today that it has filed a registration statement with the Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for...Thu, 09 Sep 2010 12:00:00 AM GMThttp://www.rttnews.com/ArticleView.aspx?Id=1409772&SM=1BILLERICA, Mass., Sep 03, 2010 (BUSINESS WIRE) -- Bruker Corporation ("Bruker") /quotes/comstock/15*!brkr/quotes/nls/brkr (BRKR 13.23, 0.64, 5.04%) , a leading global provider of high-performance scientific instruments, and Bruker Energy & Supercon Technologies, Inc. ("BEST"), a leading provider of superconducting technology and enabling tools and a Bruker subsidiary, today announced that BEST...Fri, 03 Sep 2010 12:00:00 AM GMThttp://www.google.com/hostednews/ap/article/ALeqM5h7Y4crZpF_W7HYD6lGWKcpogO5dwD9HBK94G0AP -- NEW YORK Electromed Inc., which makes a device that helps lung disease patients breathe, expects to conduct its initial public offering in the next two weeks.Tue, 03 Aug 2010 12:00:00 AM GMThttp://online.wsj.com/article/BT-CO-20100628-712797.htmlWSJ -- SurgiVision Inc. said it plans to sell 2.5 million shares of its common stock at between $13 and $15 a share in its planned initial public offering, as it begins marketing its first medical device after receiving the Food and Drug Administration's go-ahead. Wed, 30 Jun 2010 12:00:00 AM GMThttp://www.forbes.com/feeds/ap/2010/06/24/business-health-care-us-biohorizons-ipo-filing_7716336.htmlForbes -- Dental implant maker BioHorizons Inc. on Wednesday filed a registration statement for an initial public offering worth up to $100 million.Thu, 24 Jun 2010 12:00:00 AM GMThttp://www.reuters.com/article/idCNSGE6570E820100608?rpc=44Reuters -- Medical device company Tornier B.V. filed with the U.S. regulators on Tuesday to raise up to $205 million in an initial public offering. The Netherlands-based company said it will use the net proceeds to repay debt. It may use the proceeds to acquire other businesses, products or technologies, the company added.Tue, 08 Jun 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=182317&full=1SAN DIEGO--(BUSINESS WIRE)--GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol GNMK. In addition, GenMark has granted the underwriters...Tue, 01 Jun 2010 12:00:00 AM GMThttp://www.xconomy.com/seattle/2010/05/21/who-needs-vcs-steven-quays-atossa-genetics-seeks-fast-ipo-for-breast-cancer-test/Xconomy -- Most biotech firms toil as obscure private companies for years to prove their ideas work in the clinic. They have to hustle non-stop for venture capital to keep the doors open just long enough to someday cash out with an IPO.Fri, 21 May 2010 12:00:00 AM GMThttp://www.streetinsider.com/IPOs/NuPathe+Inc.+%28PATH%29+Files+$86.25M+IPO/5637564.htmlBusinessweek -- Specialty pharmaceutical company NuPathe Inc., which is developing a patch that treats migraines, on Friday filed for an initial public offering valued at up to $86.3 million.Mon, 17 May 2010 12:00:00 AM GMThttp://www.streetinsider.com/IPOs/DynaVox+%28DVOX%29+Sees+IPO+Price+of+$15+-+$17Share/5515069.htmlReuters -- DynaVox Inc said it expects proceeds of up to $150 million from its initial public offering of Class A common shares. The Delaware-based company expects to offer 9.4 million shares at $15 to $17 apiece.Fri, 09 Apr 2010 12:00:00 AM GMThttp://www.reuters.com/article/idCNSGE6370GJ20100408?rpc=44Reuters -- Medical device company Kips Bay Medical Inc filed with U.S. securities regulators on Friday to raise up to $57.5 million in an initial public offering of common stock.Thu, 08 Apr 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=174454&full=1PASADENA, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. GenMark is a Delaware corporation and, in connection with the offering, will become the parent holding company of Osmetech, plc.</p><p>Piper Jaffray & Co. will act as the sole...Fri, 19 Mar 2010 12:00:00 AM GMThttp://www.pehub.com/63033/montagu-considers-e2-billion-ipo-for-bsn-medical/<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Mon, 08 Feb 2010 12:00:00 AM GMThttp://www.canadianbusiness.com/markets/market_news/article.jsp?content=D9DHDI3G0<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Fri, 29 Jan 2010 12:00:00 AM GMThttp://www.globenewswire.com/newsroom/news.html?d=183088RICHMOND, British Columbia, Jan. 29, 2010 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today that, on January 28, 2010, Paulson Investment Company Inc.,subsidiary of Paulson Capitol Corp, (Nasdaq:PLCC), the lead underwriter of its recently completed public offering, purchased an additional 92,280 units to cover over-allotments, from which the company received net proceeds of approximately...Fri, 29 Jan 2010 12:00:00 AM GMThttp://www.pehub.com/59951/dynavox-files-for-125-million-ipo/<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Wed, 06 Jan 2010 12:00:00 AM GMThttp://www.globenewswire.com/newsroom/news.html?d=180824<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Wed, 23 Dec 2009 12:00:00 AM GMThttp://www.reuters.com/article/idCNWEN744420091211?rpc=44<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Fri, 11 Dec 2009 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idCNN3043618820091130?rpc=44<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Tue, 01 Dec 2009 12:00:00 AM GMThttp://www.rttnews.com/Content/QuickFacts.aspx?Node=B1&Id=1099836%20&Category=Quick%20Facts<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Thu, 22 Oct 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=122613&full=1<div id"releaseBody"><p>NASHVILLE, TN--(Marketwire - January 12, 2009) - <table class"releaseLink"><tr><td class"releaseLink"><b>Highlighted Links</b></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid465224&attachid902344">OralDNA Labs Web Site</a></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid465224&attachid902346">OralDNA...Mon, 12 Jan 2009 12:00:00 AM GMThttp://biz.yahoo.com/pz/081106/153974.htmlSALT LAKE CITY, Nov. 6, 2008 (GLOBE NEWSWIRE) -- On October 30, 2008, Utah Medical Products, Inc. (NasdaqGM:UTMD - News) announced that its Board of Directors approved a quarterly cash dividend of twenty-three cents ($.23) per share of common stock payable on January 5, 2009 to shareholders of record at the close of business on December 16, 2008.Thu, 06 Nov 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINN1040894320081010?rpc=44WASHINGTON, Oct 10 (Reuters) - AGA Medical Holdings Inc on Friday filed to raise up to $200 million in an initial public offering of common stock.Mon, 13 Oct 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINN1853313020080922?rpc=44NEW YORK, Sept 22 (Reuters) - Fluidigm Corp postponed its initial public offering on Monday, citing market conditions, according to one of the deal's underwriters.Tue, 23 Sep 2008 12:00:00 AM GMThttp://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/09/20/BUJU130LDL.DTLFluidigm Corp.'s intrepid drive to complete its initial public offering during one of the most turbulent weeks in Wall Street history has hit gridlock because potential buyers of the issue were scrambling to react to the seesawing market crisis, the company said Friday.Mon, 22 Sep 2008 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=109479&full=1PASADENA, Calif.--(BUSINESS WIRE)--Osmetech plc, a molecular diagnostics company, (LSE:OMH - News) (proposed NASDAQ Global Market Symbol: OSMH) today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of 5,500,000 American Depositary Shares (ADSs) (representing 192,500,000 ordinary shares...Fri, 12 Sep 2008 12:00:00 AM GMThttp://www.pehub.com/6120/xdx-cancels-ipo/XDx Inc., a South San Francisco-based molecular diagnostics company that develops tests for the monitoring of transplant rejection and autoimmune diseases, has withdrawn its registration for an $86.25 million IPO. No reason was given. The company had planned to trade on the Nasdaq, with JPMorgan and Morgan Stanley serving as co-lead underwriters.Mon, 08 Sep 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINN0440894220080904?rpc=44<p> IRVINE, Calif., Sept. 4 /PRNewswire/ -- TherOx, Inc. announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.</p><p> Citigroup Global Markets Inc. and UBS Investment Bank are acting as joint book-running managers for the offering with Cowen and Company...Fri, 05 Sep 2008 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=102308&full=1MOUNTAIN VIEW, CA--(MARKET WIRE)--Jul 3, 2008 -- ZONARE Medical Systems, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of shares of its common stock. Copies of the registration statement on Form S-1 can be accessed through the SEC's website at www.sec.gov.</p><p>Citi and Piper Jaffray...Thu, 03 Jul 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINN2036243620080620?rpc=44WASHINGTON, June 20 (Reuters) - AGA Medical Holdings on Friday filed with regulators to raise up to $200 million in an initial public offering of common stock.Mon, 23 Jun 2008 12:00:00 AM GMThttp://biz.yahoo.com/ap/080610/ccs_medical_ipo_withdrawal.html?.v=1NEW YORK (AP) -- Medical supply management company CCS Medical Holdings Inc. has canceled its proposed initial public offering of 10 million shares because difficult market conditions, according to a Securities and Exchange Commission filing on Monday.Tue, 10 Jun 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idUKWNAS533220080318?rpc=44March 18 (Reuters) - CardioNet Inc on Tuesday cut its initial public offering size to 3.4 million common shares and lowered the estimated price range of the offering to $18 to $20 a share.Wed, 19 Mar 2008 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=86327&full=1FT. LAUDERDALE, Fla., Feb. 14, 2008 (PRIME NEWSWIRE) -- MAKO Surgical Corp. announced today the initial public offering of 5,100,000 shares of its common stock at a price of $10.00 per share, all of which shares are being offered by MAKO Surgical Corp. MAKO Surgical Corp. and a selling stockholder have granted the underwriters a 30-day option to purchase up to an additional 698,333 shares and 66,...Fri, 15 Feb 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idUKWNAS122420080215?rpc=44Feb 15 (Reuters) - Concentric Medical Inc requested U.S. regulators for the withdrawal of registration of its initial public offering, citing unfavorable market conditions that would adversely affect the offering.Fri, 15 Feb 2008 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?epi-content=GENERIC&newsId=20080206005990&ndmHsc=v2*A1201698000000*B1202344981000*DgroupByDate*J2*N1000122&newsLang=en&beanID=1229976837&viewID=news_viewST. PAUL, Minn.--(BUSINESS WIRE)--Transoma Medical, Inc., announced this morning that it is postponing its initial public offering due to unfavorable market conditions. Transoma expects to proceed with the IPO at a future date and will evaluate market conditions to determine the appropriate timing.Wed, 06 Feb 2008 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=83755&full=1WALTHAM, Mass.--(BUSINESS WIRE)--BG Medicine, a medical diagnostics company, announced today that based on current market conditions, it has chosen not to proceed with its planned initial public offering at this time. The company has withdrawn its registration statement on Form S-1 as filed with the Securities and Exchange Commission.</p><p>This press release does not constitute an offer to sell...Thu, 24 Jan 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idUKN2255626820080122?rpc=44<p> ST. PAUL, Minn., Jan. 23 /PRNewswire/ -- Cardiovascular Systems, Inc. (CSI) announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its common stock. Morgan Stanley & Co. Incorporated and Citigroup Global Markets Inc. are acting as joint book-running managers of the offering, with William Blair...Wed, 23 Jan 2008 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idUKWNAS647120080115?rpc=44Jan 15 (Reuters) - Transoma Medical Inc on Tuesday said it sees its initial public offering of 4 million shares at an estimated price of $14 to $16 per share.Tue, 15 Jan 2008 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=81816&full=1<p> BUFFALO GROVE, Ill., Jan. 3 /PRNewswire/ -- Alma Lasers Ltd. ("Alma Lasers") announced today that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to its proposed underwritten initial public offering of its ordinary shares.</p><p> The initial public offering is expected to consist of newly issued shares being offered by Alma Lasers and secondary...Fri, 04 Jan 2008 12:00:00 AM GMThttp://www.reuters.com/article/governmentFilingsNews/idUSN1325371120071213WASHINGTON, Dec 13 (Reuters) - Medical device company Devax Inc on Thursday filed to withdraw plans for an initial public offering, saying such a move was "no longer in its best interests."Fri, 14 Dec 2007 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idUKWNAS387020071206?rpc=44Dec 6 (Reuters) - Molecular diagnostics company BG Medicine Inc cut the estimated price range of its initial public offering of 4.5 million shares to $8 to $10 a share, from $14 to $16 per share, according to a regulatory filing.Thu, 06 Dec 2007 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20071205ShanghaiBio Corporation, a maker of diagnostic tools that is getting into the CRO business, said it expects to make its IPO sometime during the next year. ShanghaiBio, also known as Shanghai Biochip, claims to be one of the largest biotech companies in China. SBC started by making biochips. In fact, the company is the National Engineering Center for biochip design and engineering in Shanghai. Now...Thu, 06 Dec 2007 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=78204&full=1<p> MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall/ -- Virtual Radiologic Corporation today announced the closing of its initial public offering of 4,600,000 shares of common stock at a price to the public of $17.00 per share. The offering consisted of 4,000,000 shares offered by Virtual Radiologic and an additional 600,000 shares offered by certain selling stockholders pursuant to the exercise by...Wed, 21 Nov 2007 12:00:00 AM GMThttp://www2.marketwire.com/mw/release_html_pressroom?id=F65B254181F3F030&release_id=330915MOUNTAIN VIEW, CA--(Marketwire - November 20, 2007) - Broncus Technologies, Inc., a medical technology company focused on developing and commercializing minimally invasive medical devices for emphysema and other lung diseases, today announced the filing of a registration statement with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. All...Tue, 20 Nov 2007 12:00:00 AM GMThttp://www.chron.com/disp/story.mpl/ap/fn/5304728.html NEW YORK Shares of EnteroMedics Inc. rose modestly in their first day of trading Thursday after the medical device company's initial public offering priced at the low end of a reduced price range.Shares rose 10 cents to $8.10 in afternoon trading. Shares hit a high of $8.50 and a low of $7.81 earlier in the session.Fri, 16 Nov 2007 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=77593&full=1<p> MINNEAPOLIS, Nov. 14 /PRNewswire-FirstCall/ -- Virtual Radiologic Corporation today announced the pricing of its initial public offering of 4,000,000 shares of common stock at a price of $17.00 per share. All shares were offered by Virtual Radiologic. In connection with the offering, certain selling stockholders granted the underwriters a 30-day option to purchase up to 600,000 shares of common...Thu, 15 Nov 2007 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=77658&full=1ST. PAUL, Minn.--(BUSINESS WIRE)--EnteroMedics Inc. today announced the initial public offering of 5,000,000 shares of common stock at a price of $8 per share. EnteroMedics common stock is expected to begin trading on the NASDAQ Global Market under the trading symbol ETRM on Thursday, November 15, 2007. All shares of the common stock in the offering are being sold by EnteroMedics.</p><p>J.P. Morgan...Thu, 15 Nov 2007 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=77729&full=1<p> SAN MATEO, Calif., Nov. 14 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. announced that on November 13, 2007, it closed its previously announced initial public offering of 10,000,000 shares and that the underwriters of the offering exercised their over-allotment option in full and purchased 1,500,000 additional shares of common stock at the public offering price of $8.00 per share. Including...Thu, 15 Nov 2007 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idUKWNAS212920071113?rpc=44 Nov 13 (Reuters) - BG Medicine Inc registerd its initial public offering of 4.5 million shares at an estimated price of $14 to $16 per share.The Waltham, Massachusetts-based molecular diagnostics company said in a filing with the U.S. Securities and Exchange Commission that Cowen & Co and Leerink Swann were underwriting the IPO.Tue, 13 Nov 2007 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idUKWEN240920071106?rpc=44<p> SAN MATEO, Calif., Nov. 7 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. today announced the initial public offering of 10,000,000 shares of common stock at a price of $8.00 per share. BioForm has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares at the initial public offering price to cover over-allotments, if any. The common stock will trade on the...Wed, 07 Nov 2007 12:00:00 AM GMThttp://home.businesswire.com/portal/site/biospace2/index.jsp?epi-content=GENERIC&newsId=20071106006488&ndmHsc=v2*A1193828400000*B1194469617000*DgroupByDate*G2*J2*N1003652&newsLang=en&beanID=2039556742&viewID=news_viewNORTHBROOK, Ill.--(BUSINESS WIRE)--Nanosphere, Inc. (NASDAQ: NSPH), a nanotechnology-based molecular diagnostics company, today announced that the underwriters of Nanospheres recent initial public offering of its common stock exercised in full their over-allotment option to purchase an additional 1,050,000 shares of Nanospheres common stock at $14.00 per share, less underwriting discounts and commissions...Wed, 07 Nov 2007 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=76111&full=1<p> SAN DIEGO, Nov. 2 /PRNewswire/ -- Genoptix, Inc. announced today that it has closed its previously announced initial public offering of 5,000,000 shares and that the underwriters of the offering have exercised in full their 30-day option to purchase an additional 750,000 shares of common stock, which includes 450,000 shares sold by Genoptix and 300,000 shares sold by certain selling stockholders...Mon, 05 Nov 2007 12:00:00 AM GMT